A toxin-secreting gut bacterium may fuel ulcerative colitis by killing protective immune cells that maintain intestinal ...

Market opportunities in the IBD treatment sector include the rising demand for targeted therapies and biologics due to a deeper understanding of the disease, alongside the expansion of biosimilar ...

The discovery that a toxin made by bacteria found in dirty water might help trigger ulcerative colitis could lead to new ...

James Cook University (JCU) researchers have discovered that the same chemical compounds produced by mountain-top plants to ...

A clinical trial delivering hope to people living with inflammatory bowel disease (IBD) has reached an important milestone, with initial results ...

LONDON - About 5% of the world’s population, including an estimated 3.1 million adults in the U.S., suffer from inflammatory bowel disease (IBD) – the umbrella term for Crohn’s disease and ulcerative ...

Proactive care and early treatment help prevent serious IBD complications and improve patients’ quality of life.

Digestive woes like bloating and cramps often lead to confusion between IBS and IBD. While IBS is a functional disorder ...

Inflammatory bowel disease (IBD) therapies for patients may need to be briefly halted during treatment for COVID-19, but it does not escalate IBD flares, with prior vaccination for COVID-19 helping ...